endolinx Medical News about Malignant Hypertension

Endocrinology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Endocrinology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Endocrinology

Adrenal Glands

Atherosclerosis/Lipids

Basic Science/Genetics

Bone Metabolism

Diabetes

Diagnostics

Economics of Medicine

Endocrine Oncology

Fetal Development

Hypertension

Metabolism and Growth

Neuroendocrinology

Obesity

Pediatric Endocrinology

Pharmacology/kinetics

Popular Press

Reproductive
Endocrinology

Thyroid/Parathyroid

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

FDA Update: Thyrotropin Approved For Thyroid Cancer Ablation
Tracy Hampton, PhD, MDLinx Oncology

See all

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Cerebral Hemodynamics During Treatment With Sodium Nitroprusside Versus Labetalol in Malignant Hypertension
Hypertension, 07/10/08

Email This Article

Save in My Library

Free Abstract

Immink RV et al. - Sodium nitroprusside reduced systemic vascular resistance rather than cerebral vascular resistance with a larger rate of reduction in middle cerebral artery blood velocity, suggesting a preferential blood flow to the low resistance systemic vascular bed rather than the cerebral vascular bed.

Sponsor

--- HYPERTENSION TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

A Practical "ABCDE" Approach to the Metabolic Syndrome
Mayo Clinic Proceedings, 08/05/08

Angiotensin Receptor Blockers: Current Status and Future Prospects
American Journal of Medicine, 08/25/08

Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria
Journal of Hypertension, 08/14/08

...All of Hypertension